BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
According to BB Biotech AG's latest financial reports the company's current revenue (TTM) is $-225,965,153. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
---|---|---|---|---|---|
2023 | $-225,965,153 | $-225,965,153 | $-227,877,569 | $-233,846,934 | $-233,936,384 |
2022 | $-397,686,305 | $-397,686,305 | $-404,546,772 | $-405,073,281 | $-405,142,350 |
2021 | $-448,630,850 | $-448,630,850 | $-456,073,308 | $-458,278,984 | $-458,354,847 |
2020 | $791.73 M | $791.73 M | $782.69 M | $782.69 M | $782.6 M |
2019 | $775.88 M | $775.88 M | $767.12 M | $767.12 M | $767.04 M |
2018 | $-527,361,477 | $-527,361,477 | $-486,464,759 | $-533,610,515 | $-533,690,906 |
2017 | $784.73 M | $784.73 M | $ | $778.53 M | $778.44 M |
2016 | $-901,797,603 | $-901,797,603 | $-907,121,570 | $-908,079,477 | $-908,159,868 |
2015 | $746.43 M | $746.43 M | $ | $739.26 M | $739.17 M |
2014 | $1.67 B | $1.67 B | $ | $1.66 B | $1.66 B |
2013 | $1.06 B | $1.06 B | $ | $1.06 B | $1.06 B |
2012 | $426.66 M | $426.66 M | $-1,324,764 | $416.83 M | $416.49 M |
2011 | $-1,436,860 | $-1,436,860 | $-73,655,761 | $-73,655,761 | $-73,754,269 |
2010 | $1.79 M | $1.79 M | $ | $-165,645,353 | $-165,706,496 |
2009 | $61.47 M | $61.47 M | $ | $42.38 M | $41.47 M |
2008 | $83.58 M | $83.58 M | $-9,091,053 | $51.42 M | $51.35 M |
2007 | $ | $ | $-300,646,757 | $-300,390,862 | $-300,518,809 |
2006 | $360.14 M | $360.14 M | $ | $336.86 M | $336.73 M |
2005 | $376.66 M | $376.66 M | $ | $360.26 M | $360.06 M |
2004 | $241.92 M | $241.92 M | $-244,313,704 | $229.68 M | $229.57 M |
2003 | $219.11 M | $219.11 M | $ | $203.25 M | $203.06 M |